Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,266 total articles
InterDigital, Inc. unveiled findings from a report highlighting its AI-enabled Pixel Value Reduction (PVR) technology, which extends smartphone video viewing time by up to 22% and reduces energy consumption on TVs and other devices by up to 15%. PVR optimizes display luminance and contrast to save power without compromising image quality. The techn…
Amarin Corporation plc will report its first quarter 2026 financial results on April 29, 2026, followed by a live webcast conference call with senior management. The company highlights its commitment to cardiovascular disease therapeutics and provides information on accessing the call and replay. Investors are encouraged to review posted materials …
NEXGEL, Inc. has rescheduled its shareholder update conference call to April 23, 2026 to provide updates on its potential transaction with Celularity Inc. The company announced it will not finance the transaction under its previous agreement and is negotiating a new financing structure with another investor group. Details on the transaction and fin…
T3 Defense Inc. announced its unaudited preliminary financial and operational results for Q1 2026, the company's first full quarter operating as a defense-focused holding company. The company expects Q1 revenue of approximately $4.2 million and confirms its full-year 2026 revenue guidance of $26 million, supported by a robust backlog of over $12 mi…
Achieve Life Sciences announced the successful transfer of cytisinicline manufacturing technology to US-based Adare Pharma Solutions, including completion of analytical method transfer and production of the first engineering batch. Despite previous FDA cGMP inspection concerns at the former facility, Achieve plans to resubmit its NDA with Adare as …
Brilliant Earth Group, a leading ethically sourced fine jewelry company, will report its first quarter 2026 earnings after market close on May 6, 2026, accompanied by an investor webcast and conference call. The company emphasizes its continued mission to transform the jewelry industry with sustainable practices and reports strong 2025 net sales pe…
Reviva Pharmaceuticals provided an update to shareholders detailing its recent $10 million financing to strengthen cash reserves, plans to extend the patent life of its lead drug candidate brilaroxazine through a new formulation, and preparations to initiate a second Phase 3 schizophrenia trial (RECOVER-2). The company seeks FDA alignment on the ne…
Adamas Trust, Inc., a REIT focusing on capital deployment across real estate and capital markets, will report its Q1 2026 financial results after market close on April 29, 2026, followed by a conference call on April 30, 2026.
Mobile Infrastructure Corporation (NASDAQ: BEEP), a public owner of parking infrastructure across the U.S., announced it will release its first quarter 2026 earnings after market close on May 12, 2026, followed by a conference call hosted by senior management at 4:30 PM ET the same day. The company owns 35 parking facilities in 19 U.S. markets, tot…
Filana Therapeutics announced the publication in Epilepsia of preclinical data demonstrating that their drug candidate simufilam dose-dependently attenuates seizure progression in a mouse model of severe Tuberous Sclerosis Complex (TSC)-related epilepsy. The study supports continued clinical evaluation of simufilam for TSC-related epilepsy, a rare …
LPL Financial announced that Brian Bogue has launched Texas Wealth Solutions by affiliating with LPL's Independent Advisor Network. Bogue brings approximately $235 million in assets under management and over 25 years of experience, focusing on serving pre-retirees and retirees in East Texas. This move enables him to operate independently while leve…
Vivos Therapeutics plans to release its full year 2025 financial results after market close on April 15, 2026, followed by a conference call discussing operational updates including strategic collaborations impacting near-term revenue growth and cash burn. The company focuses on innovative nonsurgical treatments for obstructive sleep apnea (OSA) an…
Carriage Services, Inc., a US-based provider of funeral and cemetery services, announced a quarterly cash dividend of 11.25 cents per share, payable June 1, 2026, to shareholders of record May 4, 2026. The company operates 155 funeral homes and 28 cemeteries across multiple states, emphasizing innovation and elevated service.
DSS, Inc. announces substantial operational progress in 2025, including a 43% reduction in costs and expenses, enhanced financial discipline, and strategic realignment into four core business segments. The company highlights growth in Product Packaging and Securities & Investment Management, completed the spin-out of Impact BioMedical, and plans a …
VAALCO Energy, Inc., a US-based independent energy company with assets in Africa, announced its participation in the Water Tower Research Virtual Conference where its CEO will discuss the company’s asset portfolio, strategic outlook, and capital allocation strategy. The company operates production, development, and exploration assets in Gabon, Egyp…
PDS Biotechnology announced encouraging interim Phase 2 clinical trial results for its tumor-targeted IL-12 immunocytokine, PDS01ADC, in patients with metastatic colorectal cancer (mCRC) with liver metastases. The trial showed a 78% objective response rate and over 80% two-year survival, significantly outperforming parallel studies without PDS01ADC…
OceanFirst Financial Corp., a regional bank primarily operating in New Jersey and the Mid-Atlantic region, declared a quarterly cash dividend of $0.20 per share. The dividend is payable on May 8, 2026, to shareholders of record as of April 27, 2026. This move highlights the company's ongoing commitment to returning value to shareholders.
Home Federal Bancorp, Inc. of Louisiana has declared a quarterly cash dividend of $0.135 per share, payable May 11, 2026, reflecting the company's stable financial performance and commitment to shareholder returns.
SNDL Inc., a major Canadian vertically integrated cannabis and liquor retailer, will release its financial results for the first quarter of 2026 on April 29, 2026, before market open. The company will hold an investor conference call and webcast on the same day to discuss the results.
XMax Inc. announced a 73% increase in net sales for fiscal year 2025, driven by its furniture business, while also embarking on a new strategic expansion into artificial intelligence technologies. The company established a subsidiary, XMax AI Inc., and partnered to build a cloud-based AI platform on AWS, signaling diversification of revenue streams…
Telos Corporation announced the launch of TSA PreCheck enrollment services at the University of Central Florida's campus, enhancing convenience for students, faculty, staff, and the surrounding community. This initiative expands access to expedited airport security screening services in the Orlando area, supporting traveler convenience through more…
Allbirds, Inc. announced a $50 million convertible financing facility to fund its strategic pivot from footwear to AI compute infrastructure. Following the sale of its brand and footwear assets to American Exchange Group, the company plans to become NewBird AI, a GPU-as-a-Service and AI-native cloud provider targeting the unmet demand for high-perf…
NOV Inc. announced that operational disruptions caused by the Middle East conflict have led to lower than expected first quarter 2026 revenues and earnings. The company now expects $2.05 billion in revenue, $47 million in operating profit, and $177 million in Adjusted EBITDA, impacted by estimated $54 million revenue and $32 million EBITDA losses d…
Calidi Biotherapeutics (NYSE American: CLDI) announced its participation in RedChip's virtual investor conference on April 16, 2026, focusing on its innovative RedTail platform for targeted genetic medicines. The company highlighted the upcoming IND filing for CLD-401, its lead candidate targeting solid tumors using systemic virotherapy, and discus…
Vivos Therapeutics, Inc. announced its full year 2025 financial results highlighting a 16% increase in revenue to $17.5 million driven by the integration of The Sleep Center of Nevada and expanded sleep testing services. Despite gross margin stability at 60%, operating expenses significantly increased due to integration costs, leading to a larger o…
